Delivering on the Dream:Biomedical Research in the Genomic Era

FEATUREThe Human Genome Project +5Delivering on the Dream: Biomedical Research in the Genomic Era BY FRANCIS S. COLLINS Francis S. Collins is the director of the National Human Genome Research Institute, National Institutes of HealthWith the sequencing of the genomes of Homo sapiens and a wide array of other organisms, biology has emerged as a truly quantitative science. Researchers from all realms of biology - from botany to zool

Written byFrancis S. Collins
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Biomedical Research in the Genomic Era

With the sequencing of the genomes of Homo sapiens and a wide array of other organisms, biology has emerged as a truly quantitative science. Researchers from all realms of biology - from botany to zoology - can now tap vast troves of genomic information available in free, public databases. Still, what excites me the most is the potential of this genome-based, quantitative approach to transform biomedical research and, ultimately, health care.

I am scientist, but also a physician. Since the early deliberations about the Human Genome Project nearly 20 years ago, I have dreamed of the day when we would be able to apply the tools of genomics to the diagnosis, treatment, and prevention of common diseases. Successfully sequencing the genomes of human and other strategically selected organisms represents a major step, but a first step nonetheless.

The recently completed map of human genetic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies